The CEO of OptumRx, one of the country’s largest pharmacy benefit managers, said the company has had significant interest from commercial clients in transitioning to point-of-sale rebate models like the one proposed by the Trump administration for Medicare Part D and Medicaid managed care. Company leaders also maintained that the point-of-sale rebate proposal would not hurt the company’s bottom line. UnitedHealth’s transition to point-of-sale rebates is well underway, executives said, and is spreading. OptumRx CEO John Prince said the PBM’s...